Medical Economics October 29, 2024
Grace Halsey

Key Takeaways

  • Over 75% of family and internal medicine physicians have prescribed GLP-1 receptor agonists for weight loss.
  • The survey examined physicians’ experiences with GLP-1RAs, focusing on effectiveness, side effects, and cost.
  • Physicians and patients consider both the benefits and potential drawbacks, including side effects and financial implications.

Doctors offer insights on the how they and their patients are using GLP-1RA medicines.

If it feels like the new antiobesity medicines are everywhere, you may not far off.

More than three-quarters of family medicine...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Primary care, Provider, Survey / Study, Trends
Related Articles:
New PAGB research highlights importance of self-care for easy-to-treat conditions
Sentara dives into the 'future of primary care'
I built an empire nobody wants
Mass General Brigham primary care physicians eye unionizing
Making Life Better at the Bottom of the Healthcare Pyramid

Share This Article